Dietary Supplement Label Database

Ferrex 150

On market
Photo of the Breckenridge Pharmaceutical Ferrex 150 label
Photo of the label, from the NIH's original record · Open full size ↗
Supplement Facts
Serving Size 1-2 Capsule(s)
Servings Per Container 100
Amount Per Serving% Daily Value
Iron (as as Polysaccharide-Iron)Iron (Form: as Polysaccharide-Iron) Note: elemental150 mg833%

Other ingredients: Sodium Lauryl Sulfate, Gelatin, Stearic Acid, Polyethylene Glycol, Microcrystalline Cellulose, Citric Acid, Croscarmellose Sodium, Titanium Dioxide, Polyvinylpyrrolidone, FD&C Yellow #5 Lake, FD&C Red #40 Lake, FD&C Red #3 Lake, FD&C Blue #1 Lake

% Daily Values for: Adults and children 4 or more years of age.

Where this label comes from

An original label of the NIH's Dietary Supplement Label Database, entered there on 23 July 2020, shown here as it was entered. The NIH's record

General information

Product name
Ferrex 150
Brand
Breckenridge Pharmaceutical
Barcode (UPC)
3 51991 20311 7
Net contents
100 Unit Dose Capsule(s)
Market status
On market
DSLD ID
230127

Classification

Supplement form
Capsule
Product type
Mineral
Claim types on the label
All Other, Approved Health, Structure/Function
Intended for
Adult (18 - 50 Years)

Label statements

Precautions: All Other: Do not use if blister seals are broken

FDA Statement of Identity: Dietary Supplement

Formula: Contains: Ferrex 150 Polysaccharide-Iron Complex Capsules are a product of ferric iron complexed to a low molecular weight polysaccharide.

Directions: Indication and Usage Ferrex 150 may be used for the dietary management of iron deficiencies.

Precautions: Allergies: Contraindications Ferrex 150 is contraindicated in patients with a known hypersensitivity to any of the components of this product.

Precautions: All Other: Hemochromatosis and hemosiderosis are contraindications in the use of this dietary supplement.

Precautions: Allergies: Precautions This product contains FD&C Yellow No. 5 Lake (Tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 Lake (Tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.

Precautions: All Other: The type of anemia and the underlying cause or causes should be determined before initiating supplementation with Ferrex 150. Since the anemia may be a result of a systematic disturbance, such as a recurrent blood loss, the underlying cause or causes should be corrected if possible.

Precautions: Children: As with all oral iron preparations, Ferrex 150 should be stored out of the reach of children to protect against accidental iron poisoning.

Precautions: All Other: Patients should not exceed the recommended dosage unless directed by a physician. Patients should be informed that iron products can cause dark or black stools.

Precautions: Pregnant or Nursing or Prescription Medications: Since oral iron products interfere with absorption of certain antibiotics, these products should not be taken within two hours of each other.

Precautions: Pregnant or Nursing or Prescription Medications: If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.

Precautions: Children: Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions: All Other: Adverse Reactions Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stool and abdominal pain. Adverse reactions with iron therapy are usually transient.

Precautions: All Other: Overdosage The clinical cause of acute iron overdose can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Directions: Dosage and Administration Usual adult dosage is one or two capsules daily, or as directed by a physician or health-care provider. Do not exceed recommended dosage.

Precautions: Children: Warning: Keep this and all medications out of the reach of children.

Storage: Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP controlled room temperature. Protect from light and moisture.

FDA Statement of Identity: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Precautions: All Other: To report a serious adverse event contact: 1-800-367-3395. Warning: Reproductive harm - www.P65Warnings.ca.gov.

Formula: Contains: Polysaccharide-Iron Complex Capsules

Brand information

Manufactured by: Contract Pharmacal Corp., Hauppauge, NY

Distributed by: Breckenridge Pharmaceutical, Inc., Berlin, CT

More labels from Breckenridge Pharmaceutical

Every Breckenridge Pharmaceutical label ›

Labels only: each label is shown as printed on the bottle, with no grades, rankings or advice. A label in this database is not an endorsement of the product. Read the label on the bottle you buy: makers change their formulas. Reverse Age Lab is not affiliated with, or endorsed by, the National Institutes of Health or its Office of Dietary Supplements. The original labels come from the NIH’s public-domain data; the labels since are read by us. Search the Dietary Supplement Label Database.